Will Interest Rates Rise on 5 November? What It Means for Pharmacy Loans

What did the Bank of England decide?

Update, 6 November 2026. The Bank of England raised Bank Rate by 0.25 percentage points to 4% on 5 November, by eight votes to one, with one member voting for 4.25% (Monetary Policy Summary and minutes). The Bank expects inflation of around 5% by the middle of 2027 and said policy is not on a pre-set path. Several members said a further rise may be needed. The next decision is on 17 December 2026. Our report on what the rise to 4% means for practice loans covers the decision in full. The rest of this article, written before the announcement, still applies at 4%.

Will the Bank of England raise interest rates on 5 November 2026?

It looks likely. The Bank of England announces its next Bank Rate decision at noon on Thursday 5 November, one of the 2026 meeting dates it set in advance, with a full Monetary Policy Report alongside. A Reuters poll reported by Sovereign Magazine on 28 October found 54 of 63 economists expecting Bank Rate to rise from 3.75% to 4%, which would be the first rise in more than three years.

The reason is inflation. The ONS September inflation figures showed CPI at 3.5%, up from 3.1% in August, with motor fuel prices up 29.8% over the year. At the September meeting three of the nine members already voted to raise rates, and Governor Andrew Bailey said that if the conflict pushing up energy prices persists, "it is likely that policy may have to tighten".

Why does a rate rise matter to pharmacy owners?

Buying a pharmacy is one of the more borrowing-heavy deals in professional practice. Most of the price is goodwill tied to the NHS contract, and buyers usually fund it with a long-term acquisition loan secured on the business and often the premises. Many of those loans are priced as a margin over Bank Rate or SONIA, so a rise feeds straight into the monthly repayment. Our guide to buying a pharmacy walks through how these deals are put together.

Existing owners feel it too. Variable-rate loans taken to buy the business, refit the premises or fund a second branch will cost more, and so will overdrafts and revolving facilities used to smooth the gap between buying stock and being paid by the NHS. Fixed-rate loans and hire purchase agreements you have already signed will not change.

How much would a rise to 4% add to a pharmacy loan?

A quarter point rise adds about £250 a year in interest for every £100,000 of variable-rate borrowing that tracks Bank Rate. Here is what that looks like on typical pharmacy borrowing.

• £500,000 acquisition loan. About £1,250 a year, or around £104 a month.
• £1 million acquisition loan. About £2,500 a year, or around £208 a month.
• £150,000 revolving facility, fully drawn. About £375 a year.

Pharmacy acquisition loans from banks and specialist healthcare lenders are priced differently from one another, so the gap between lenders on the same deal is usually worth far more than a quarter point. Our guide to what practice purchase finance costs sets out the fees as well as the rate, and the practice purchase loan calculator runs your own numbers.

Does a rate rise change what lenders will lend on a pharmacy?

It can, at the margin. Lenders test whether the pharmacy's profit covers the loan repayments with room to spare, and a higher rate means a bigger repayment on the same loan. A deal that only just passed at 3.75% may need a slightly larger deposit or a longer term at 4%. Most well-run pharmacies will not notice the difference, but a buyer stretching to the limit should ask the lender to run the numbers at the new rate before relying on an offer.

The other side of the test is income, and that has improved. The 2026 to 2027 Community Pharmacy Contractual Framework raised funding to £3.636 billion, up £340 million or 10.3% on 2025 to 2026, lifted the retained medicine margin by £200 million to £1.1 billion and raised the single activity fee from £1.46 to £1.52. It also adds independent prescribing from autumn 2026, with a £500 set-up fee and a £525 monthly payment. Our report on pharmacist prescribing in Pharmacy First covers what that pays. Lenders look at the income a buyer can show, so put the new fees into your forecast.

Should I fix the rate on a pharmacy acquisition loan?

A fixed rate gives certainty over the repayments for the fixed period, which is worth a lot when the business is new to you and the cash flow is still settling. The trade-off is that fixed deals often carry early repayment charges, and lenders price new fixed loans off market rates that have already moved up in anticipation of a rise. Ask for fixed and variable quotes on the same deal and compare the total cost over the period you expect to keep the loan.

If you already hold a variable loan, this is a good time to look at refinancing. Moving to a fixed rate, or consolidating several facilities into one, can make repayments more predictable. Our refinancing hub explains how lenders assess a switch.

Should I buy a pharmacy now or wait for rates to settle?

Do not let a quarter point decide the deal. The price of the business, the contract, the prescription volumes and the premises matter far more than the rate on the day you sign, and good pharmacies do not stay on the market waiting for rates to fall. If inflation keeps rising, the next move is more likely to be up than down, so waiting may not help.

What does help is preparation. Lenders move faster on a pharmacy purchase when the buyer arrives with three years of accounts, recent NHS payment schedules, a business plan that includes the new prescribing income, and a clear view of the deposit. Our guide to preparing a practice finance application lists what to gather, and buying a professional practice covers the steps from offer to completion.

Which types of pharmacy finance are least affected?

• Fixed-rate loans. Unsecured practice loans are usually fixed, so the repayment stays the same for the term.
• Equipment finance. Equipment finance for dispensing robots, consultation rooms and IT is normally fixed when you sign. See IT and software finance for prescribing systems.
• Fit-out finance. Refurbishment finance for a new consultation room is often available on a fixed rate.
• Tax funding. VAT funding and corporation tax funding are short fixed-cost loans that spread a bill over a few months.

The products most exposed are variable acquisition and premises loans, overdrafts and revolving facilities, so those are the ones to check first.

What it means for your funding

A rate rise on 5 November would make variable pharmacy borrowing a little dearer, but it does not change lenders' appetite for well-run pharmacies, and the 2026 to 2027 contract has given owners more income to show them. If you are buying, get current quotes rather than relying on one from last month, ask for fixed and variable options, and test the deal at the higher rate. If you already own a pharmacy, check which of your facilities are variable and whether a refinance would steady the repayments.

We are a broker, not a lender. We compare whole of market options for pharmacy practice loans, practice acquisition finance, goodwill finance and working capital, and approach the lenders that suit your pharmacy. Instant Quotes shows which lenders on our panel fit your deal, with no credit check. See how it works, or read more practice finance news.

Common questions

Published 2 November 2026, updated 6 November 2026. Figures and dates are taken from the sources named and were correct on that date. This article is for general information only and should not be treated as legal, tax, accounting or financial advice. Funding availability and lender requirements depend on individual circumstances.